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Abstract1 
Concentrated liquid L-lysine (base) and L-lysine HCl, produced by genetically modified (GM) strains of 
Corynebacterium glutamicum, and L-lysine sulphate (solid and liquid) produced by non-GM strains of 
C. glutamicum, were the subject of this application. The use of L-lysine HCl produced by the GM C. 
glutamicum ‘A’ in animal nutrition was considered a hazard due to the presence of a recombinant 
antibiotic resistance gene. The use in animal nutrition of concentrated liquid L-lysine (base) produced 
using C. glutamicum ‘A’ was considered of no concern for the target species, consumer and the 
environment. The FEEDAP Panel could not conclude on the safety of concentrated liquid L-lysine 
(base) and L-lysine HCl produced by the GM C. glutamicum ‘B’ or ‘C’ for the target animals, consumers 
and environment due to the absence of adequate data on the absence of the production strain or its 
recombinant DNA in the products. The identity of strain ‘C’ as C. glutamicum was also not confirmed.  
For L-lysine sulphate originating from non-GM strains C. glutamicum ‘D’, ‘E’ or ‘F’, the FEEDAP Panel 
could not conclude on the safety for the target species, the consumer and the environment due to 
uncertainties that these products might contain antibiotic resistance genes. In addition, the intrinsic 
high sulphate content in those products might have the potential to cause adverse effects in target 
species. The FEEDAP Panel reiterated its concerns on the safety of the administration of amino acids, 
including L-lysine, via water for drinking because of the risk of imbalances and for hygiene reasons. 
Due to the uncertainties described above, the FEEDAP Panel could not conclude on the safety for 
users or the environment of all products under assessment except concentrated liquid L-lysine (base) 
produced using C. glutamicum ‘A’. The products under assessment would be considered efficacious 
sources of L-lysine for non-ruminant species. For these sources of supplemental L-lysine to be as 
efficacious in ruminants as in non-ruminant species, they would require protection against degradation 
in the rumen.  
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Summary2 
Following a request from European Commission, the Panel on Additives and Products or Substances 
used in Animal Feed was asked to deliver a scientific opinion on concentrated liquid L-lysine (base), L-
lysine monohydrochloride (HCl) technically pure and L-lysine sulphate (solid and/or liquid) produced 
by fermentation by different strains of Corynebacterium glutamicum (hereafter referred as ‘A’, ‘B’, ‘C’, 
‘D’, ‘E’ and ‘F’), for all animal species. 
L-Lysine is an essential amino acid for all animal species. L-Lysine and its salts are widely used in the 
feed industry to optimise the amino acid profile of diets in order to improve animal performance.  
The use of the amino acid L-lysine itself in animal nutrition is considered safe for target animals, 
consumers, and the environment.  
The use of L-lysine HCl technically pure produced using C. glutamicum ‘A’ in animal nutrition was 
considered a hazard for the target species, consumer, user and environment due to the presence of a 
recombinant antibiotic resistance gene in most batches of the product. The use of concentrated liquid 
L-lysine (base) produced by C. glutamicum ‘A’ in animal nutrition was considered of no concern for the 
target species, consumer and the environment. 
The FEEDAP Panel could not conclude on the safety of the products concentrated liquid L-lysine (base) 
and L-lysine HCl, technically pure, produced using C. glutamicum ‘B’ (the presence of the production 
strain and/or its recombinant DNA could not be excluded) or ‘C’ (incomplete data on identification of 
the species, safety of the genetic modification, potential for antibiotic resistance and the 
presence/absence of the production strain and its recombinant DNA in the products) for the target 
animal species, consumer, the user and the environment. 
The FEEDAP Panel could not conclude on the safety of L-lysine sulphate solid and/or liquid originating 
from C. glutamicum ‘D’, ‘E’ or ‘F’. The genetic basis of resistance to at least one antibiotic used in 
medical and veterinary practice was not sufficiently elucidated. In addition, the intrinsic high sulphate 
content in the product might have the potential to cause adverse effects in target species. 
Regardless of the assessment of the genetic modification, potential transmissible antibiotic resistance 
or absence of toxicological studies, the FEEDAP Panel had concerns on the safety of the 
administration of the amino acids, including L-lysine, via water for drinking because of the risk of 
imbalances and for hygiene reasons.  
The lack of any significant dermal or eye irritant potential along with evidence for lack of respiratory 
toxicity and dermal sensitisation indicated that there is no significant concern regarding user safety for 
the L-lysine sulphate products. Concentrated liquid L-lysine (base) is considered as corrosive due to its 
high pH. In the absence of data, the FEEDAP Panel could not conclude on the dermal sensitisation and 
on the irritancy of L-lysine HCl to skin or eyes. The concerns regarding the safety of the genetic 
modification and potential presence of transmissible resistance to antibiotics might also have 
implications for the safety of the user. 
Concentrated liquid L-lysine base and L-lysine HCl, technically pure produced by fermentation with 
strains C. glutamicum ‘A’, ‘B’ or ‘C’, and L-lysine sulphate (both solid and liquid) produced by 
fermentation with strains C. glutamicum ‘D’, ‘E’ or ‘F’ are regarded as efficacious sources of the 
essential amino acid L-lysine for non-ruminant animal species. For these sources of supplemental L-
lysine to be as efficacious in ruminants as in non-ruminant species, they would require protection 
against degradation in the rumen. 
The FEEDAP Panel made some recommendations concerning (i) the description of the additives and 
(ii) the importance of considering the contribution of sulphate from the additive when using L-lysine 
sulphate supplementation in feed. 
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